NYSE:CRL
Charles River Laboratories International Stock News
$221.61
-3.14 (-1.40%)
At Close: May 17, 2024
Charles River Dives As Monkey Investigation Hamstrings 2023 Outlook
09:38am, Wednesday, 22'nd Feb 2023
Charles River Laboratories announced a shortfall in monkey shipments on Wednesday that weighed on its 2023 outlook, and CRL stock toppled. The post Charles River Dives As Monkey Investigation Hamstrin
Charles River (CRL) Introduces Novel IgY-Based ELISA Kit
12:03pm, Tuesday, 14'th Feb 2023
Charles River's (CRL) HCP-ELISA is built on its HCP-GAPex service, enhancing the efficiency and efficacy of HCP assay development.
Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call
08:30am, Thursday, 09'th Feb 2023
WILMINGTON, Mass.
Charles River (CRL) to Report Q4 Earnings: What's in Store?
09:47am, Monday, 30'th Jan 2023
The broad-based demand and meaningful price increases in the RMS business particularly in North America are expected to have contributed to Charles River's (CRL) top line in Q4.
Final Trades: Abbvie, Goldman Sachs, Charles River & more
03:56pm, Friday, 20'th Jan 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Charles River's (CRL) New CDMO Tie-Up to Boost Clinical Trials
02:18pm, Friday, 20'th Jan 2023
Charles River's (CRL) latest partnership is expected to bring a potentially curative therapy, RZ-001, to HCC patients.
Charles River (CRL) to Develop RNA-based Therapy With New Pact
12:02pm, Thursday, 19'th Jan 2023
Charles River's (CRL) new partnership will enable the clinical development of RNA-based anticancer gene therapy in liver cancer patients.
Charles River (CRL) to Advance DNA Programs With New Launch
12:48pm, Friday, 13'th Jan 2023
Charles River's (CRL) launch of the eXpDNA plasmid manufacturing platform is intended to support vaccine and advanced therapy clients through clinical trials and beyond.
Here's Why You Should Retain Charles River (CRL) Stock Now
12:21pm, Wednesday, 28'th Dec 2022
Investors are optimistic about Charles River (CRL) on robust performances across the RMS and DSA segments.
Charles River (CRL) Benefits From Price Rise Amid FX Woe
09:47am, Tuesday, 20'th Dec 2022
Charles River's (CRL) RMS growth prospects are high, courtesy of accelerating growth for research model services and research models.
Charles River Laboratories International, Inc. (CRL) Q3 2022 Earnings Call Transcript
04:38pm, Wednesday, 02'nd Nov 2022
Charles River Laboratories International, Inc. (NYSE:CRL ) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET Company Participants Todd Spencer - VP, IR James Foster - Chairman, President &
Charles River (CRL) Q3 Earnings Top Estimates, Margins Dip
12:48pm, Wednesday, 02'nd Nov 2022
Headwinds associated with foreign exchange due to the strengthening of the U.S. dollar and interest expense due to a rising interest rate environment increase concerns for Charles River (CRL).
Why Charles River Laboratories Stock Is Jumping Today
12:18pm, Wednesday, 02'nd Nov 2022
Investors liked the company's Q3 update.
Charles River Laboratories (CRL) Tops Q3 Earnings and Revenue Estimates
09:48am, Wednesday, 02'nd Nov 2022
Charles River (CRL) delivered earnings and revenue surprises of 4.78% and 1.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Charles River Laboratories: Near-Term Headwinds Outweigh Long-Term Tailwinds
03:27pm, Tuesday, 18'th Oct 2022
Shares of Charles River have been hard hit by operational missteps, but shares are not cheap enough to buy yet. While its safety unit has done very well, its CDMO unit has been slow to build momentum
